AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Raphael Pharmaceutical Inc.

$1.4 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$1.4
Day Range
$1.4 - $1.4
Year Range
$0.22$1.4
Market Cap
28.25M
AVG Volume
171
Trailing/Forward PE
-28.46/-
PEG ratio
-0.6
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD)
-600K-400K-200K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-223K
26 Q1-229K
25 Q4-273K
25 Q3-255K
25 Q2-322K
25 Q1-429K
24 Q4-395K
24 Q3-326K
24 Q2-248K
Operating Income (USD)
-600K-400K-200K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-199K
26 Q1-223K
25 Q4-254K
25 Q3-251K
25 Q2-315K
25 Q1-425K
24 Q4-394K
24 Q3-319K
24 Q2-249K
EBITDA (USD)
-600K-400K-200K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-198K
26 Q1-223K
25 Q4-254K
25 Q3-251K
25 Q2-315K
25 Q1-425K
24 Q4-394K
24 Q3-319K
24 Q2-249K
Cash Flows (USD)
-300K-200K-100K0100K200K24 Q225 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q20
26 Q1-44K
25 Q4-142K
25 Q3171K
25 Q2-30K
25 Q1-209K
24 Q2-217K
EPS (USD)
-0.03-0.02-0.01024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.01
26 Q1-0.01
25 Q4-0.01
25 Q3-0.01
25 Q2-0.02
25 Q1-0.02
24 Q4-0.02
24 Q3-0.02
24 Q2-0.01
Expenses (USD)
0200K400K600KR&DSG&A24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2198K
26 Q1223K
25 Q4345K
25 Q3251K
25 Q2315K
25 Q1425K
24 Q4394K
24 Q3319K
24 Q2249K
Cash & Debt (USD)
050K100K150KCashShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q21K
26 Q11K
25 Q445K
25 Q33K
25 Q220K
25 Q150K
24 Q419K
24 Q340K
24 Q2120K
Debt ratios
-0.06-0.04-0.0200.0225 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.05
26 Q1-0.03
25 Q40.01
25 Q3-0.03
25 Q2-0.01
25 Q10.01
Return on Capital
0%25%50%75%100%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Return on Capital by quarter
PeriodReturn on Capital
26 Q211.83%
26 Q113.78%
25 Q419.05%
25 Q320.17%
25 Q230.73%
25 Q158.45%
24 Q453.23%
24 Q352.92%
24 Q285.52%
Shares Outstanding
010M20M30M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Shares Outstanding by quarter
PeriodShares Outstanding
26 Q220.18M
26 Q120.18M
25 Q419.91M
25 Q319.63M
25 Q219.63M
25 Q119.63M
24 Q419.15M
24 Q318.7M
24 Q218.68M
Book Value Per Share (USD)
-0.1-0.08-0.05-0.03-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-0.09
26 Q1-0.08
25 Q4-0.07
25 Q3-0.06
25 Q2-0.05
25 Q1-0.04
24 Q4-0.04
24 Q3-0.03
24 Q2-0.02
Total Assets (USD)
050K100K150K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RAPH Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q27K
26 Q13K
25 Q453K
25 Q37K
25 Q230K
25 Q193K
24 Q427K
24 Q351K
24 Q2128K
Employee Count
01232008
RAPH Employee Count by quarter
PeriodEmployee Count
20082
Free Cash Flow Yield
-0.8%-0.6%-0.4%-0.2%-0%med -0.16%Apr 26May 26Jun 26Jul 26Aug 26Sep 26
RAPH Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-0.05%
Sep 26-0.05%
Aug 26-0.05%
Aug 26-0.05%
Aug 26-0.05%
Aug 26-0.16%
Jul 26-0.16%
Jul 26-0.16%
Jul 26-0.16%
Jul 26-0.16%
Jul 26-0.16%
Jun 26-0.16%
Jun 26-0.16%
Jun 26-0.16%
Jun 26-0.16%
May 26-0.16%
May 26-0.16%
May 26-0.16%
May 26-0.75%
May 26-0.75%
Apr 26-0.75%
Apr 26-0.75%
Apr 26-0.75%
Apr 26-0.75%
Raphael Pharmaceutical Inc.
RAPH
Stockpicker

Video analysis: RAPH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.